Fig. 1From: Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patientsVaccination schedule and PBMC collection. The vaccination consisted of two cycles: the first one at weekly administration × 4 weeks (First cycle) and the second with fortnightly administration × 5 (Second cycle), for a total of nine administrations. Pt = Patient; V = vaccine administration; PBMCs = peripheral blood mononuclear cells; Arrows = PBMC collectionBack to article page